Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Iraqi women with PCOS often have higher testosterone levels and obesity.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

Hirsutism moderately affects the quality of life for most women, linked to condition severity.

WomenCare helps predict PCOD risk in women to encourage early medical consultation.

Multimedia education greatly improves women's knowledge and management of PCOS.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

A very low-calorie ketogenic diet led to weight loss and improved metabolic and hormonal health in obese men, with better sperm motility.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.